Skip to content

Characterization of oral-intestinal flora in patients with pancreatic cancer

Characterization of oral-intestinal flora of pancreatic cancer patients and study of Chinese medicine evidence pattern

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001710
Enrollment
Unknown
Registered
2025-09-11
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic

Interventions

Group of pancreatic cancer patients:NA

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1 Inclusion criteria for pancreatic cancer patients: 1) Meet the western medical diagnostic criteria and Chinese medicine identification criteria for pancreatic cancer; 2) Have not received chemotherapy radiotherapy targeted therapy immunotherapy or other anti-tumor treatment for pancreatic cancer; 3) The age is 18~75 years old gender is not limited; 4) Subjects agree and voluntarily sign the informed consent form. 2 Inclusion criteria for healthy volunteers: 1) Select the people who had their medical checkups in our medical checkup center during the same period and the results of this medical checkup are normal; (2) Age 18~75 years old gender is not limited; (3) Subjects agreed and voluntarily signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Malignant tumors that have been treated with chemotherapy radiotherapy targeted therapy immunotherapy or other antitumor therapies; 2) Previous oral diseases; 3) Combined diabetes viral hepatitis and other diseases that may cause dry mouth symptoms; 4) History of previous gastrointestinal diseases such as: gastroenteritis peptic ulcer inflammatory bowel disease irritable bowel syndrome gastrointestinal tumors etc; (5) Use of glucocorticoids and antibiotics in the last 2 months; (6) Use of probiotic preparations (e.g. Bacillus licheniformis live bacterial capsule Bacillus subtilis capsule) within the last 1 week Probiotic preparations etc. If any of the above criteria is met it will be excluded.

Design outcomes

Primary

MeasureTime frame
flora;

Countries

China

Contacts

Public ContactQuanwang Li

Dongfang Hospital Beijing University of Chinese Medicine

quanwangli@126.com+86 136 9137 1560

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026